ICU Medical Inc (ICUI)
93.64
-3.08
(-3.18%)
USD |
NASDAQ |
Apr 25, 12:39
ICU Medical Enterprise Value: 3.709B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 3.709B |
| April 23, 2024 | 3.734B |
| April 22, 2024 | 3.701B |
| April 19, 2024 | 3.686B |
| April 18, 2024 | 3.713B |
| April 17, 2024 | 3.689B |
| April 16, 2024 | 3.700B |
| April 15, 2024 | 3.718B |
| April 12, 2024 | 3.745B |
| April 11, 2024 | 3.806B |
| April 10, 2024 | 3.784B |
| April 09, 2024 | 3.917B |
| April 08, 2024 | 3.860B |
| April 05, 2024 | 3.829B |
| April 04, 2024 | 3.810B |
| April 03, 2024 | 3.869B |
| April 02, 2024 | 3.851B |
| April 01, 2024 | 3.919B |
| March 28, 2024 | 3.965B |
| March 27, 2024 | 3.858B |
| March 26, 2024 | 3.807B |
| March 25, 2024 | 3.743B |
| March 22, 2024 | 3.742B |
| March 21, 2024 | 3.753B |
| March 20, 2024 | 3.724B |
| Date | Value |
|---|---|
| March 19, 2024 | 3.764B |
| March 18, 2024 | 3.768B |
| March 15, 2024 | 3.742B |
| March 14, 2024 | 3.756B |
| March 13, 2024 | 3.818B |
| March 12, 2024 | 3.809B |
| March 11, 2024 | 3.873B |
| March 08, 2024 | 3.897B |
| March 07, 2024 | 3.918B |
| March 06, 2024 | 3.873B |
| March 05, 2024 | 3.849B |
| March 04, 2024 | 3.957B |
| March 01, 2024 | 3.918B |
| February 29, 2024 | 4.011B |
| February 28, 2024 | 4.090B |
| February 27, 2024 | 3.953B |
| February 26, 2024 | 3.924B |
| February 23, 2024 | 3.875B |
| February 22, 2024 | 3.860B |
| February 21, 2024 | 3.889B |
| February 20, 2024 | 3.914B |
| February 16, 2024 | 3.946B |
| February 15, 2024 | 3.960B |
| February 14, 2024 | 3.776B |
| February 13, 2024 | 3.763B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.803B
Minimum
Oct 14 2019
6.798B
Maximum
Apr 20 2022
4.381B
Average
4.181B
Median
Feb 20 2020
Enterprise Value Benchmarks
| Integer Holdings Corp | 5.054B |
| LeMaitre Vascular Inc | 1.325B |
| ResMed Inc | 28.05B |
| UFP Technologies Inc | 1.665B |
| Perspective Therapeutics Inc | 984.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.15M |
| Revenue (Quarterly) | 587.86M |
| Total Expenses (Quarterly) | 593.30M |
| EPS Diluted (Quarterly) | -0.71 |
| Gross Profit Margin (Quarterly) | 29.19% |
| Profit Margin (Quarterly) | -2.92% |
| Earnings Yield | -1.31% |
| Operating Earnings Yield | 2.12% |
| Normalized Earnings Yield | -0.2501 |